IP Library Granted Patent US 7,125,979
Granted Patent B2
US 7,125,979 · App. 10/336,091 · Granted Oct 24, 2006

Upstream control elements of the proopiomelanocortin gene and their use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,125,979
App. No.
10/336,091
Granted
Oct 24, 2006
Kind
B2
Abstract

The nucleic acid sequence of the POMC enhancer is disclosed herein. Sequences from the human, rat, rabbit, hamster, mouse, and cow POMC enhancer are disclosed. Hybrid transgenes, comprising a POMC transcriptional control element operably linked to a nucleic acid sequence encoding a marker are also enclosed. In addition, transgenic mice carrying a hybrid transgene including a POMC control element operably linked to a marker are disclosed herein.

Claims (25)

1. An isolated proopiomelanocortin enhancer element, comprising a nucleic acid sequence set forth as SEQ ID NO: 15, wherein the isolated proopiomelanocortin enhancer element elevates transcription of a heterologous coding sequence in a host cell.

2. The isolated proopiomelanocortin enhancer element of claim 1 , consisting of a nucleic acid sequence set forth as SEQ ID NO: 15.

3. The isolated proopiomelanocortin enhancer element of claim 1 , operably linked to a promoter and a heterologous nucleic acid sequence, wherein the enhancer element directs expression of the heterologous nucleic acid sequence in a proopiomelanocortin neuron.

4. The isolated proopiomelanocortin enhancer element of claim 1 , comprising a nucleic acid sequence set forth as SEQ ID NO: 10, or SEQ ID NO: 13.

5. The isolated enhancer element of claim 4 , operably linked to a nucleic acid sequence encoding a heterologous polypeptide.

6. The isolated enhancer clement of claim 5 , wherein the nucleic acid sequence encoding a heterologous polypeptide encodes an enzyme, a marker, antibiotic resistance polypeptide or an antigen.

7. The isolated enhancer element of claim 5 , wherein the nucleic acid sequence encoding a polypeptide encodes green fluorescent protein.

8. The isolated enhancer element of claim 1 , operably linked to a heterologous promoter.

9. An expression vector comprising the isolated enhancer element of claim 1 and a promoter.

10. The expression vector of claim 9 , wherein the vector is a viral vector.

11. The expression vector of claim 9 , wherein the vector is a plasmid vector.

12. An isolated host cell transformed with the vector of claim 9 .

13. The isolated host cell of claim 12 , wherein the host cell is a eukaryotic cell.

14. The isolated host cell of claim 12 , wherein the host cell is a prokaryotic cell.

15. An expression cassette comprising the POMC enhancer of claim 1 , and a nucleic acid sequence encoding proopiomelanocortin comprising at least one exon, wherein a polylinker comprising a unique site for a restriction enzyme is inserted into the exon.

16. The isolated proopiomelanocortin enhancer element of claim 1 , wherein the heterologous coding sequence encodes a marker polypeptide.

17. The isolated enhancer element of claim 1 , comprising a nucleic acid sequence set forth as SEQ ID NO: 10.

18. The isolated enhancer element of claim 1 , comprising a nucleic acid sequence forth as SEQ ID NO: 13.

19. An expression vector comprising the isolated enhancer element of claim 16 and a promoter.

20. The vector of claim 19 , wherein the vector is a viral vector.

21. The vector of claim 19 , wherein the vector is a plasmid vector.

22. An isolated host cell transformed with the vector of claim 19 .

23. The isolated host cell of claim 22 , wherein the host cell is a eukaryotic cell.

24. The expression vector of claim 19 , wherein the isolated enhancer element comprises a sequence set forth as SEQ ID NO: 13.

25. An isolated host cell transformed with the vector of claim 19 , wherein the isolated enhancer element comprises a sequence set forth as SEQ ID NO:13.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 29, 2008
From: OREGON HEALTH AND SCIENCE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 020870/0791 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2003
From: LOW, MALCOLM; RUBINSTEIN, MARCELO; SOUZA, FLAVIO SILVA JUNQUIERA DE
To: OREGON HEALTH & SCIENCE UNIVERSITY
Reel/Frame 013960/0157 →